{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:40:32Z","timestamp":1784576432739,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jval.2021.04.1274","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T12:12:34Z","timestamp":1624536754000},"page":"1279-1284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Opioid Prescribing in United States Health Systems, 2015 to 2019"],"prefix":"10.1016","volume":"24","author":[{"given":"Tumader","family":"Khouja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Matusiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jval.2021.04.1274_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2017.0935","article-title":"History of the Joint Commission\u2019s pain standards: lessons for today\u2019s prescription opioid epidemic","volume":"317","author":"Baker","year":"2017","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jval.2021.04.1274_bib2","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1056\/NEJMc1700150","article-title":"A\u00a01980 letter on the risk of opioid addiction","volume":"376","author":"Leung","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jval.2021.04.1274_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2105\/AJPH.2016.303228","article-title":"Are pain management questions in patient satisfaction surveys driving the opioid epidemic?","volume":"106","author":"Adams","year":"2016","journal-title":"Am J Public Health"},{"issue":"15","key":"10.1016\/j.jval.2021.04.1274_bib6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2021.04.1274_bib8","article-title":"Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada","volume":"362","author":"Gomes","year":"2018","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.jval.2021.04.1274_bib9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ajhp\/zxz109","article-title":"National trends in prescription drug expenditures and projections for 2019","volume":"76","author":"Schumock","year":"2019","journal-title":"Am J Health Syst Pharm"},{"issue":"15","key":"10.1016\/j.jval.2021.04.1274_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/ajhp\/zxaa116","article-title":"National trends in prescription drug expenditures and projections for 2020","volume":"77","author":"Tichy","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"10180","key":"10.1016\/j.jval.2021.04.1274_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(19)30428-3","article-title":"Inappropriate opioid prescription after surgery","volume":"393","author":"Neuman","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jval.2021.04.1274_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.annemergmed.2019.04.007","article-title":"Conversion to persistent or high-risk opioid use after a new prescription from the emergency department: evidence from Washington Medicaid beneficiaries","volume":"74","author":"Meisel","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"6","key":"10.1016\/j.jval.2021.04.1274_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.jval.2021.04.1274_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.surg.2019.04.016","article-title":"New persistent opioid use among older patients following surgery: a Medicare claims analysis","volume":"167","author":"Santosa","year":"2020","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.jval.2021.04.1274_bib15","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1213\/ANE.0000000000002458","article-title":"Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic","volume":"125","author":"Hah","year":"2017","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jval.2021.04.1274_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.jval.2021.04.1274_bib17","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1007\/s11999-015-4173-5","article-title":"Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery","volume":"473","author":"Menendez","year":"2015","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.jval.2021.04.1274_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1213\/ANE.0000000000000836","article-title":"Postoperative hypoxemia is common and persistent: a prospective blinded observational study","volume":"121","author":"Sun","year":"2015","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.jval.2021.04.1274_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcna.2018.02.005","article-title":"Preventing opioid overdose in the clinic and hospital: analgesia and opioid antagonists","volume":"102","author":"Peglow","year":"2018","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.jval.2021.04.1274_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/bmjqs-2020-011295","article-title":"Assessment of a quality improvement intervention to decrease opioid prescribing in a regional health system","volume":"30","author":"Brown","year":"2021","journal-title":"BMJ Qual Saf"},{"issue":"7","key":"10.1016\/j.jval.2021.04.1274_bib23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJMc1905045","article-title":"Statewide implementation of postoperative opioid prescribing guidelines","volume":"381","author":"Vu","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jval.2021.04.1274_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/SLA.0000000000003462","article-title":"Description and impact of a comprehensive multispecialty multidisciplinary intervention to decrease opioid prescribing in surgery","volume":"270","author":"Kaafarani","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.jval.2021.04.1274_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jss.2019.09.051","article-title":"Implementation of a quality improvement initiative to decrease opioid prescribing in general surgery","volume":"247","author":"Pruitt","year":"2020","journal-title":"J\u00a0Surg Res"},{"issue":"2","key":"10.1016\/j.jval.2021.04.1274_bib26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1213\/ANE.0000000000004018","article-title":"American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus statement on perioperative management of patients on preoperative opioid therapy","volume":"129","author":"Edwards","year":"2019","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jval.2021.04.1274_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/pm\/pnaa211","article-title":"Impact of opioid restrictions during a critical drug shortage period: interrupted time series for institutional opioid utilization","volume":"22","author":"Brokenshire","year":"2021","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.jval.2021.04.1274_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5055\/jom.2018.0434","article-title":"The parenteral opioid shortage: causes and solutions","volume":"14","author":"Hollingsworth","year":"2018","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.jval.2021.04.1274_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ajem.2020.03.010","article-title":"The effects of a morphine shortage on emergency department pain control","volume":"43","author":"Kettler","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jval.2021.04.1274_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.06.016","article-title":"Fatal misuse of transdermal fentanyl patches","volume":"302","author":"Geile","year":"2019","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.jval.2021.04.1274_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-019-00723-0","article-title":"Patch problems? Characteristics of transdermal drug delivery system exposures reported to the national poison data system","volume":"16","author":"Thornton","year":"2020","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.jval.2021.04.1274_bib33","unstructured":"U.S. Food & Drug Adminstration. Abuse-Deterrent Opioid Analgesics. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/abuse-deterrent-opioid-analgesics. Accessed November 1, 2020"},{"issue":"12","key":"10.1016\/j.jval.2021.04.1274_bib34","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/hec.3944","article-title":"Adverse health effects of abuse-deterrent opioids: evidence from the reformulation of OxyContin","volume":"28","author":"Beheshti","year":"2019","journal-title":"Health Econ"},{"issue":"6","key":"10.1016\/j.jval.2021.04.1274_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5055\/jom.2017.0415","article-title":"Do abuse deterrent opioid formulations work?","volume":"13","author":"Dart","year":"2017","journal-title":"J\u00a0Opioid Manag"},{"issue":"4","key":"10.1016\/j.jval.2021.04.1274_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jval.2018.12.005","article-title":"Impact of abuse deterrent formulations of opioids in patients with chronic pain in the United States: A cost-effectiveness model","volume":"22","author":"Kumar","year":"2019","journal-title":"Value Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521014947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521014947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:24:09Z","timestamp":1761096249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301521014947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1098301521014947"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.04.1274","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Prescribing in United States Health Systems, 2015 to 2019","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.04.1274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}